Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 991 AL 1005

Multidimensional cognitive deficit in logopenic variant primary progressive aphasia: a case report

Puspitasari V, Ramli Y, Lastri DN, Prawiroharjo P, Wijaya JH.

J Med Case Rep. 2026 May 29;20(1):302. doi: 10.1186/s13256-026-06137-1.

Language performances in dementia with Lewy bodies and Alzheimer's disease: A longitudinal comparative study of naming and fluency

Labernède F, Lausecker A, Sanna L, Philippi N, Demuynck C, Cretin B, Muller C, Blanc F, Chabran É.

J Alzheimers Dis. 2026 Apr;110(4):1870-1885. doi: 10.1177/13872877261427500. Epub 2026 Mar 26.

Advanced diffusion MRI tract signatures in Alzheimer's disease, dementia with Lewy bodies, and the FTD/PPA spectrum

Tian Y, Whitwell JL.

Neuroimage. 2026 Jul 1;334:121984. doi: 10.1016/j.neuroimage.2026.121984. Epub 2026 May 8.

Use of anti-amyloid-β monoclonal antibodies in persons with Down syndrome Alzheimer's disease

Farrell C, Saini F, Beidas MM, Ryan NS, Strydom A, Wiseman FK.

Alzheimers Dement. 2026 Apr;22(4):e71404. doi: 10.1002/alz.71404.

Sensitivity comparison of longitudinal cognitive function indicators of Alzheimer's disease after mild cognitive impairment: a prospective cohort study

Guo G, Song W, Wang A, Cui Q, Yang X, Wang Y, Ma Y, Han H, Li Z, Zhang Z, Meng W, Wang S, Shi F.

Sci Rep. 2026 Mar 22;16(1):14503. doi: 10.1038/s41598-026-44192-2.

[Epidemiological studies of the association between dyslipidemia and Alzheimer's disease]

Tong FF, Huang RQ, Gao Y, Luo QQ, Chen YP, Xu GZ.

Zhonghua Liu Xing Bing Xue Za Zhi. 2026 Apr 10;47(4):767-774. doi: 10.3760/cma.j.cn112338-20250727-00528.

A phase 2, randomized, multicenter, double-blind, placebo-controlled trial of S-adenosyl methionine in participants with mild cognitive impairment or dementia due to Alzheimer's disease

Holper S, Barnham KJ, Churilov L, Yates P, Brodtmann A, Johns S, Li QX, Bhalala O, Chin KS, Loveland P, Yu JJ, Masters CL, Watson R, Yassi N.

Alzheimers Dement. 2026 Apr;22(4):e71381. doi: 10.1002/alz.71381.

Validation of the Turkish Version of the DDQ-30: Norms and Clinical Utility for Detecting Lexical-Semantic Impairments

Karalı FS, Tosun S, Eskioğlu Eİ, Dicle M, Çavdar D, Çınar N, Macoir J.

Arch Clin Neuropsychol. 2026 Jan 30;41(1):acaf093. doi: 10.1093/arclin/acaf093.

Therapeutic Options for Alzheimer's Disease and Aging-Associated Cognitive Decline: State of the Art in the ACH2.0 Paradigm

Volloch V, Rits-Volloch S.

Int J Mol Sci. 2026 Feb 2;27(3):1486. doi: 10.3390/ijms27031486.

Alcohol-Induced Dysregulation of Hydrogen Sulfide Signaling in Alzheimer's Disease-Narrative Mechanistic Synthesis Review

Munteanu C, Popescu C, Vlădulescu-Trandafir AI, Maraver F, Carbajo JM, Onose G.

Int J Mol Sci. 2026 Feb 6;27(3):1595. doi: 10.3390/ijms27031595.

Time From Initial Community-Based Dementia Consultation to Confirmed Diagnosis: A Retrospective Analysis

Yamazaki A, Mishina M, Sakamoto Y, Suda S.

Psychogeriatrics. 2026 Mar;26(2):e70148. doi: 10.1111/psyg.70148.

Application of Photostimulation Therapy in Cognitive Function of Alzheimer's Disease Patients: A Scoping Review

Xu B, Wan H, Liu P, Zhao Z, Xie Y, Meng J, Qin Y.

Clin Interv Aging. 2026 Apr 24;21:600468. doi: 10.2147/CIA.S600468. eCollection 2026.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias